HanAll Biopharma (KRX: 009420.KS) will participate in the Korea Bio Investment Conference (KBIC) 2021 on Tuesday, December 7, 2021. Seung-Kook Park, PhD, President and Chief Executive Officer, will present at 4 p.m. KST.
The presentation will also be available online via the KBIC's Youtube channel at https://youtu.be/XB74fsms9Pg.
The conference, taking place December 6-7, 2021, aims to introduce Korea-based biopharmaceutical companies and novel drug pipeline assets to investors, and will be held offline and streamed live online.
NextHanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update
PrevHanAll Biopharma Initiates Dosing in VELOS-3, a Second Phase 3 of HL036 in Patients with Dry Eye Disease (DED)